MeSH D011618 - psychotic disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Abbott Biotherapeutics | Chlorpromazine | Chlorpromazine |  | 1982-01-01 |  |  |
| Accord Healthcare | Clozapine | Clozapine |  | 2015-11-25 |  |  |
| Quetiapine | Quetiapine |  | 2016-11-01 |  |  | |
| Ajanta Pharma | Olanzapine | Olanzapine |  | 2017-05-30 |  |  |
| Fluphenazine | Fluphenazine |  | 2023-01-05 |  |  | |
| Alembic Pharmaceuticals | Quetiapine | Quetiapine |  | 2014-10-28 |  |  |
| Chlorpromazine | Chlorpromazine |  | 2023-07-18 |  |  | |
| Fluphenazine | Fluphenazine |  | 2024-07-23 |  |  | |
| Alexza Pharmaceuticals | Loxapine | Adasuve | 2022-05-20 | 2012-12-21 |  |  |
| Alkem Laboratories | Olanzapine | Olanzapine |  | 2015-10-20 |  |  |
| Quetiapine | Quetiapine |  | 2013-02-12 |  |  | |
| Alkermes | Olanzapine, Samidorphan | Lybalvi | 2025-11-23 | 2021-05-28 | $259.273 M | Q4/23-Q3/24 |
| Allergan | Chlorpromazine | Chlorpromazine |  | 1982-01-01 |  |  |
| Droperidol | Droperidol |  | 1991-11-27 |  |  | |
| Fluphenazine | Fluphenazine |  | 1987-12-18 |  |  | |
| Haloperidol | Haloperidol |  | 1988-05-17 |  |  | |
| Lorazepam | Lorazepam |  | 1987-03-23 |  |  | |
| Loxapine | Loxapine |  | 1988-06-15 |  |  | |
| Loxapine | Loxitane Im |  | 1982-01-01 |  |  | |
| Perphenazine | Perphenazine |  | 2016-10-17 |  |  | |
| Amitriptyline, Perphenazine | Perphenazine Amitriptyline |  | 1986-08-25 |  |  | |
| Quetiapine | Quetiapine |  | 2013-02-27 |  |  | |
| Thioridazine | Thioridazine |  | 1983-08-23 |  |  | |
| THIOTHIXENE | Thiothixene |  | 1987-06-25 |  |  | |
| Trifluoperazine | Trifluoperazine |  | 1988-06-23 |  |  | |
| Almatica Pharma | Lorazepam | Loreev | 2034-01-08 | 2021-08-27 |  |  |
1
2
3
4
5
6
...
14
>
Clinical Trials
Historical Success Rate
Phase 1
73%32/44
Phase 2
72%64/89
Phase 3
66%55/83
Approved: 27Overall Success rate: 35%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
9
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use